$KEQU

Phillips Elizabeth D sold (to issuer) $181K of KEQU

Phillips Elizabeth D (SVP, People & Culture) sold (to issuer) 4,995 shares of KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) at $36.25 ($0.18M total) on 2026-06-30.

Original reporting
SEC EDGAR · Phillips Elizabeth D
Published Jul 2, 2026, 3:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 4:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KEQU
Neutral
medium confidence
Mentioned
$KEQU
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KEQUNeutralLow
01

Why it matters

The newest fact is the specific insider sale: 4,995 shares at $36.25 on 2026-06-30 under code D, with post-transaction holdings of 9,909 shares.

02

Market read

This provides incremental transparency on insider activity but does not introduce new fundamental catalysts.

03

What to watch

No 10b5-1 plan is cited; however, the transaction code (D) and “sale to issuer” typically reduce interpretive value versus open-market sales.

Relevance 4/10Novelty 3/10Timing: filed 2026-07-02 (after-hours/market close timing not specified)

Background

The article is an SEC Form 4 insider transaction disclosure for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU).

Company-level read

Ticker impact

$KEQUNeutralMedium confidence
Context

SEC Form 4 shows KEQU SVP sold 4,995 shares to the issuer at $36.25 on 2026-06-30, leaving 9,909 shares.

Expected impact

Low likelihood of a near-term price catalyst from this single Form 4 transaction.

Evidence & confidence

The filing is primary-source but describes a modest insider transaction; it does not include new company guidance, contracts, or regulatory actions.

Market effects

No sector read-across; this is an individual insider transaction with no operational disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is to the issuer (often buyback-related), it may reflect mechanical participation rather than bearish insider views.

Key entities

  • KEWAUNEE SCIENTIFIC CORP /DE/

    Subject of the Form 4 insider transaction disclosure (KEQU).

  • Phillips Elizabeth D

    SVP, People & Culture; sold shares to the issuer under SEC Form 4.

Related articles

$KEQUMed

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU): Results of Operations and Financial Condition

KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 prfy26q4earningsrelease.htm EX-99.1 Document Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III 704/871-3274 STATESVILLE, N.C. June 23, 2026 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ